Compare CURX & MMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CURX | MMA |
|---|---|---|
| Founded | 2018 | 2013 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.5M | 11.8M |
| IPO Year | 2025 | 2023 |
| Metric | CURX | MMA |
|---|---|---|
| Price | $0.45 | $0.49 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 192.0K | ★ 386.8K |
| Earning Date | 09-09-2025 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.26 | $0.35 |
| 52 Week High | $9.18 | $2.00 |
| Indicator | CURX | MMA |
|---|---|---|
| Relative Strength Index (RSI) | 50.62 | 54.25 |
| Support Level | $0.38 | $0.35 |
| Resistance Level | $0.53 | $0.71 |
| Average True Range (ATR) | 0.06 | 0.06 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 33.93 | 74.45 |
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout.
MMA Inc develops technology solutions for the martial arts and combat sports sector. Its platform is designed to support gyms and related businesses by improving areas such as sales channels, customer onboarding, and member engagement. The platform also connects participants, gyms, and communities within the sector, enabling digital management and interaction.